The grand event has concluded, yet its brilliance continues.

On March 15, the 2026 Boao Health Food Science Conference & Expo (FHE2026) officially came to a close. Lianyungang Jinkang Hexin Pharmaceutical Co., Ltd. presented its technological achievements from 19 years of deep cultivation in the active folate field at the event. From guidance by academicians and a keynote speech by the Chief Scientist, to winning a major industry award, the company gained extensive attention throughout the exhibition. With its China-originated technology of naturalized folate (Magnafolate), Jinkang Hexin explored new paths for industrial innovation and development with global colleagues in the food and health sector.

Academicians visited and provided guidance, and the core technologies were officially recognized

On the first day of the exhibition, Mr. Chen Junshi, academician of the Chinese Academy of Engineering and a leading authority in nutrition and food safety, visited the Jinkang Hexin booth B27. Accompanied by an on-site explanation from Dr. Lian Zenglin, the company’s Chief Scientist, Academician Chen Junshi gained a detailed understanding of the R&D history of Magnafolate, its globally exclusive patent layout for Form C crystals, and its full-scenario application implementation. He highly affirmed the product’s industry-leading advantages in purity, safety, and bioavailability, and encouraged the enterprise to continue deepening its focus on the folate segment and safeguard public health through original technologies.

During the exhibition, the Jinkang Hexin booth maintained strong popularity. The company comprehensively demonstrated the core advantages of its globally exclusive Form C crystal calcium 6S-5-methyltetrahydrofolate raw material, the full product portfolio of Shengbei & Bei’anxi, as well as application solutions for diverse scenarios including milk powder, dietary supplements for special medical purposes, and wheat flour. The professional team provided one-on-one in-depth communication and consultation. On the opening day alone, the booth received over 200 industry partners, and dozens of enterprises expressed intentions for in-depth cooperation on-site.

Delivering a Keynote Speech: Four Core Advantages Unlock New Industrial Opportunities

At the conference’s innovative seminar, Professor Lian Zenglin delivered a keynote speech entitled "Naturalized Folate Boosts Innovation and Development of the Food and Health Industry". He comprehensively elaborated on the industrial value of Magnafolate from four core advantages, providing a China-originated solution for ingredient upgrading and innovation in the food and health industry.

As the world’s first active folate of Form C crystal, Magnafolate has established a three-tier patent pool covering "basic patents, standard-essential patents, and application patents". It holds more than 40 authorized invention patents worldwide, covering more than 30 countries and regions including China, the United States, Europe, Japan and South Korea. It is also the first active folate product in China to pass the U.S. FDA on-site inspection, and has obtained many globally authoritative certifications such as HALAL, Kosher, ISO9001 and GRAS.

During the speech, Professor Lian Zenglin used detailed experimental data to comprehensively analyze the product’s core competitiveness: It meets practical non-toxic safety standards, fundamentally avoiding the risk of unmetabolized folic acid accumulation and making it suitable for sensitive groups such as pregnant women and infants. It offers 100% bioavailability, with direct intestinal absorption to achieve precise supplementation without any loss. In response to the fact that 78.4% of the Chinese population has folic acid metabolic disorders, it enables efficient supplementation for all people across the entire life cycle, thoroughly solving the pain points of traditional folic acid supplementation. The speech triggered in-depth exchanges and wide resonance among industry colleagues on site.

Returning with Honors, Winning the FHE2026 Innovative Health Technology Product Award

With globally leading original technologies, scientifically proven product strength, and extensive industrial application value, Jinkang Hexin’s naturalized folate (Magnafolate) stood out from hundreds of competing products at the conference and was awarded the FHE2026 Innovative Health Technology Product Award. This award serves as an authoritative recognition from the Boao Health Food Science Conference for the product’s technological innovation, scientific value and market potential. It also represents high affirmation from the industry of Jinkang Hexin’s leading position in the field of active folate.

Conclusion marks a new beginning. Building a new industrial ecosystem together with Chinese technologies

This trip to Boao is not only a comprehensive showcase of Jinkang Hexin’s technological strength in naturalized folate, but also a brand-new starting point for the company to join hands with global partners in the food and health industry for win-win cooperation.

As the pioneer in the research and innovation of naturalized folate, Jinkang Hexin will continue to focus on exclusive raw material supply, patent licensing, open standards, and scientific research support to build a closed-loop industrial ecosystem covering upstream and downstream. It will provide comprehensive technical and implementation support for partners across all industrial chain links, and promote the in-depth application of naturalized folate in full-lifecycle health sectors including prenatal and postnatal care, chronic disease prevention and treatment, and healthcare innovation. The conclusion is not an end. In the future, Jinkang Hexin will continue to open its patents, technologies and industrial resources. With its original active folate technology exceeding global standards, it will inject sustained momentum into the innovative development of the food and health industry, and solidify the cornerstone of national health with Chinese science and technology.

Note: Some authorized invention patents are listed below:

CN201410280541.4, US9150982, EP2805952, KR10-1694710, JP6166736, CA2861891, IN342588